Page History

...

• Lack of coordination to ensure jurisdictions are collaborating and are aligned on testing,
  compliance and conformance expectations
• Limited opportunity for vendors to test and prove core capabilities (e.g., generation of a
  compliant Patient Summary document) required for a jurisdictional integration
• Variation in jurisdictional requirements that lead to multiple unscalable solution designs across
  jurisdictions

To address the current state challenges, this Roadmap will focus on the establishment of a first-class conformity assessment program. Conforming a number of core services at the pan-Canadian level will result in the opportunity for predictable growth, while allowing for different deployment architectures across jurisdictions.

...

• Development of a pan-Canadian Conformity Assessment program tied to the Reference
  Architecture (Building Block #4) that enables vendor solution capability assessment against
  core ecosystem expectations
• Deployment of a first-class conformity assessment platform (e.g., Gazelle) that provides
  the infrastructure for jurisdictions and vendors to leverage core testing capabilities for the
  standardized components referenced above

...

As several Canadian jurisdictions prepare for Limited Production Rollouts (LPR), testing will be focused on interoperability demonstrations based on the pan-Canadian Patient Summary (PS-CA v1.1.0 DFT) and the associated pan-Canadian FHIR Exchange (CA:FeX v1.0.0 TI and/or CA:FeX v2.0.0 DFT) specifications. The PS-CA specification defines the building blocks to create and share patient summaries. The CA:FeX specification promotes FHIR RESTful exchange patterns that can be applied on top of existing non-FHIR infrastructure and FHIR servers. These two specification packages support secure exchange of a patient’s health summary document, are represented using the normative release 4.0.1 of the HL7® FHIR® standard, and are closely aligned to the International Patient Summary specification (IPS).

Testing & Tools Overview

...

This Guide focuses on conformance self-testing, that allows vendors to access to the Gazelle platform and tools, to test and self-assess their implementations against the pan-Canadian specifications. 

Vendors will have an opportunity to test and demonstrate capabilities in two distinct areas of the specification:

...

2. Secure, exchange transactions

This area of testing is focused on validating the recommended secure exchange methods of the FHIR patient summary document as presented in the Reference Architecture (RA v0.1.1 DFT), linked to the PS-CA and CA:FeX specifications.

...

Infoway has created training webinars to support the use of the tools and integrations with the Gazelle test framework. Once registered, vendors may access the Gazelle platform for self / pre-Conformance testing. In addition to Gazelle, Infoway provides a number of testing tools, including Simulators , Emulators and Validators to support the exchange patterns listed in the PS-CA specification. Test cases, including scenarios for single tests and group testing are available, along with data set to support document format and content validation for the PS-CA is available.

For more details about each of these topics, please refer to the following:

• Gazelle Access: Register your system for testing in the Gazelle Platform - Gazelle Registration (PDF)
• Training & Test Tools: Training webinars & testing tools were prepared for the 2023 Projectathon and remain relevant for 2024 Conformance testing. Please visit the Training & Test Tools page for details.
• Testing: The testing approach for the 2024 Conformance testing will following follow the same approach as the 2023 Projectathon, except that testing will focus on the PS-CA v1.1.0 DFT and the associated pan-Canadian FHIR Exchange CA:FeX v1.0.0 TI and/or CA:FeX v2.0.0 DFT.  Navigate to the Test Cases page for details and refer to the applicable appropriate specifications where applicable.  This page will provide details about the two key areas that will be tested:
  1. PS-CA Document Format and Content - ensuring that the Patient Summary document is structured in the expected format and that it contains the required information using the correct data types and valuesets, where specific valuesets are defined as required in the PS-CA.
  2. PS-CA Secure, Exchange Transactions - ensuring that at least one core integration profile (CA:FeX or MHD) can be successfully tested.
• Test Data Sets: Test data sets may be used in support of the test cases focused on ensuring that the Patient Summary document is structured in the expected format and that it contains the required information using the correct data types and valuesets, where specific valuesets are defined as required in the national (PS-CA).

The following table provides the clinical data sets for testing the PS-CA . This data may support No-Peer and Peer-to-Peer testing. 

...